Pharmacokinetics and metabolism of benzene in Zymbal gland and other key target tissues after oral administration in rats.
Solid tumors have been reported in the Zymbal gland, oral and nasal cavities, and mammary gland of Sprague-Dawley rats following chronic oral administration of benzene. The cause for the specificity of such lesions remains unclear, but it is possible that tissue-specific metabolism or pharmacokinetics of benzene is responsible. Metabolism and pharmacokinetic studies were carried out in our laboratory with 14C-benzene at oral doses of 0.15 to 500 mg/kg to ascertain tissue retention, metabolite profile, and elimination kinetics in target and nontarget organs and in blood. Findings from those studies indicate the following: a) the Zymbal gland is not a sink or a site of accumulation for benzene or its metabolites even after a single high dose (500 mg/kg) or after repeated oral administration; b) the metabolite profile is quantitatively different in target tissues (e.g., Zymbal gland, nasal cavity), nontarget tissues and blood; and (c) pharmacokinetic studies show that the elimination of radioactivity from the Zymbal gland is biphasic.
Low
L K
LK
Mobil Oil Corporation, Environmental and Health Science Laboratory, Princeton, NJ 08540.
Meeks
J R
JR
Norris
K J
KJ
Mehlman
M A
MA
Mackerer
C R
CR
D000284:Administration, Oral; D000818:Animals; D001554:Benzene / Q000008:administration & dosage / Q000378:metabolism* / Q000493:pharmacokinetics; D002250:Carbon Radioisotopes; D002851:Chromatography, High Pressure Liquid; D004424:Ear Canal / Q000378:metabolism; D005260:Female; D006207:Half-Life; D007408:Intestinal Absorption; D009297:Nasal Mucosa / Q000378:metabolism; D009928:Organ Specificity; D051381:Rats; D011919:Rats, Inbred Strains; D012627:Sebaceous Glands / Q000378:metabolism; D014018:Tissue Distribution
D002250:Carbon Radioisotopes; D001554:Benzene